Advertisement

 

 

MSMB gene rs10993994 polymorphism increases the risk of prostate cancer.

MSMB gene rs10993994 polymorphism increases the risk of prostate cancer.
Author Information (click to view)

Peng T, Zhang L, Zhu L, Mi YY,


Peng T, Zhang L, Zhu L, Mi YY, (click to view)

Peng T, Zhang L, Zhu L, Mi YY,

Advertisement
Share on FacebookTweet about this on TwitterShare on LinkedIn

Oncotarget 2017 02 14() doi 10.18632/oncotarget.15312
Abstract

Genome-wide association studies (GWASs) identified microseminoprotein-β (MSMB) gene rs10993994 polymorphism was significantly associated with prostate cancer (PC) risk. However, the association between MSMB gene rs10993994 polymorphism and PC risk remains controversial. Therefore, we performed a systematic review and meta-analysis by searching in the databases of PubMed, and Embase. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) were calculated by using fixed-effect or random-effect models. A total of 11 publications containing 13 case-control studies for rs10993994 polymorphism were included in our analysis. Our data indicated that MSMB gene rs10993994 polymorphism was associated with an increased risk of PC. Stratification analyses of ethnicity suggested rs10993994 polymorphism increased the risk of PC among Caucasians, but not among Asians. In conclusion, this meta-analysis indicates that MSMB gene rs10993994 polymorphism increases the risk of PC.

Submit a Comment

Your email address will not be published. Required fields are marked *

3 × 2 =

[ HIDE/SHOW ]